Tuberculosis in Nigeria

Tuberculosis data for Nigeria include estimates of disease occurring in the population and cases notified through the national programme. Reading both helps distinguish the burden of illness from activity recorded by health services. [1] [2]

Medically reviewed

Dr. Fitsum Admasu Tinsae

General Medicine, Public Health, Digital Health

Medical review applies to the clinical background reproduced from our tuberculosis guide.

Page review recorded: 16 Oct 2026Reviewer profile →

Clinical background

TB infection and TB disease are different. A person can be infected with Mycobacterium tuberculosis without symptoms or contagiousness. Some people later develop TB disease, especially if immunity is weakened. Disease in the lungs is called pulmonary TB; disease elsewhere in the body is called extrapulmonary TB. [1] [4]

Read the full tuberculosis guide

Tuberculosis data in Nigeria

Estimated new or recurrent TB episodes

510,000 new or recurrent TB episodes

Nigeria, 2024

Population: All ages; all forms of TB

Age: All ages

Sex: All sexes

Denominator: Not applicable — absolute count

Uncertainty: Source range 333,000–724,000

Method: WHO global TB database country burden model estimates, frozen 31 October 2026

Interpretation: WHO model estimate; includes new and recurrent TB episodes.

Source [1]

TB incidence

219 cases per 100,000 people (crude)

Nigeria, 2024

Population: All ages; all forms of TB

Age: All ages

Sex: All sexes

Denominator: Country population; all ages

Uncertainty: Source range 143–311

Method: WHO global TB database country burden model estimates, frozen 31 October 2026

Interpretation: WHO model estimate; includes new and recurrent TB episodes.

Source [1]

Total TB cases notified in 2025

458,534 notifications

Nigeria, 2025

Population: TB notifications reported by the Nigerian national programme

Age: All ages

Sex: Both sexes

Denominator: Not applicable: administrative count

Method: National programme notifications as reported by WHO Nigeria

Interpretation: Total notifications may differ from new-and-recurrent notifications; not estimated incident episodes. Do not divide by a different-year model estimate to calculate detection coverage.

Source [2]

Tuberculosis burden and notifications

The WHO database snapshot used here estimates 510,000 new or recurrent TB episodes in Nigeria in 2024, with a source range of 333,000–724,000. The incidence rate is 219 per 100,000 population, with a source range of 143–311. These estimates cover all ages and all forms of TB. [1]

WHO Nigeria reports 458,534 total TB notifications for 2025. Notifications are administrative reports of cases reaching the programme. They are presented separately from estimated incidence, and the 2025 total is not divided by the 2024 burden estimate to calculate coverage. [2]

Reference periods and database versions

The 2024 estimates retain the WHO database version verified on 31 October 2026. They are a dated evidence series rather than a claim to represent the newest annual release. Estimates may be revised when WHO updates its methods or source data; changes between database versions are not automatically changes in transmission. [1]

Total notifications and new-and-recurrent notifications are not interchangeable measures. This profile retains the wording “total” attached to the 2025 WHO Nigeria figure and does not convert it into a count of new infections. [2]

Nigeria’s tuberculosis programme

The Federal Ministry of Health and Social Welfare leads the response through the National Tuberculosis, Buruli Ulcer and Leprosy Control Programme. WHO’s March 2026 account describes expansion of rapid testing, community case finding and work to reach women and children. [2]

Organizations and official resources

Common questions

Frequently asked questions

Sources

  1. WHO Global TB database — 2024 burden estimates (31 October 2026 snapshot) — World Health Organization
  2. Nigeria intensifies tuberculosis response to close detection gaps — WHO Regional Office for Africa
  3. Public Health Policies: national sickle cell and hypertension guidelines — Federal Ministry of Health and Social Welfare